Scynexis cGMP Facilities Audited by FDA — No Form 483 Observations Issued

SCYNEXIS, Inc., a fully-integrated drug discovery and development company, announced that the U.S. Food and Drug Administration (FDA) completed its cGMP compliance inspection of the SCYNEXIS Process Chemistry, Analytical and Manufacturing facilities.
GEN